Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance
- PMID: 19077686
- PMCID: PMC2847451
- DOI: 10.1097/MNH.0b013e32831a9e0b
Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance
Abstract
Purpose of review: To review the recent evidence demonstrating how the renal dopaminergic and angiotensin systems control renal electrolyte balance through various receptor-mediated pathways with counterregulatory interactions.
Recent findings: Stimulation of the renal rennin-angiotensin system results in increased sodium reabsorption, whereas the opposite is true for stimulation of the renal dopaminergic system. An underactive renal dopaminergic system has been associated with increased sodium reabsorption and hypertension. Recent findings indicate novel cell surface receptor-mediated mechanisms by which these two renal endocrine systems directly counterregulate each other. Each of the dopamine receptors (D1R through D5R) have been implicated in dopamine-mediated natriuresis, in addition to counterregulating the angiotensin type 1 R. Dopamine D1-like (D1R and D5R) stimulation has also been found to induce an AT2 receptor- dependent natriuresis. Recently, it has also been discovered that reactive oxygen species can play a role in inactivating the D1 receptor and activating the angiotensin type 1 R.
Summary: Current therapeutic interventions for hypertension predominantly involve correction of an overactive rennin-angiotensin aldosterone system. Recent evidence suggests that stimulation of the renal dopaminergic system and possibly activation of AT2 receptors, as well as decreasing reactive oxygen species, may provide additional therapeutic approaches.
Similar articles
-
Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential.Clin Exp Pharmacol Physiol. 2013 Aug;40(8):527-34. doi: 10.1111/1440-1681.12059. Clin Exp Pharmacol Physiol. 2013. PMID: 23336117 Free PMC article. Review.
-
Renal dopamine and angiotensin II receptor signaling in age-related hypertension.Am J Physiol Renal Physiol. 2013 Jan 1;304(1):F1-7. doi: 10.1152/ajprenal.00441.2012. Epub 2012 Oct 24. Am J Physiol Renal Physiol. 2013. PMID: 23097467 Free PMC article. Review.
-
Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells.Hypertension. 2012 Aug;60(2):396-403. doi: 10.1161/HYPERTENSIONAHA.112.194175. Epub 2012 Jun 18. Hypertension. 2012. PMID: 22710646 Free PMC article.
-
Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism.Hypertension. 2007 Jan;49(1):155-61. doi: 10.1161/01.HYP.0000251881.89610.ee. Epub 2006 Nov 20. Hypertension. 2007. PMID: 17116755
-
The Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.PLoS One. 2016 Jan 11;11(1):e0146641. doi: 10.1371/journal.pone.0146641. eCollection 2016. PLoS One. 2016. PMID: 26751218 Free PMC article.
Cited by
-
Increased AT1 receptor expression mediates vasoconstriction leading to hypertension in Snx1-/- mice.Hypertens Res. 2021 Aug;44(8):906-917. doi: 10.1038/s41440-021-00661-x. Epub 2021 May 10. Hypertens Res. 2021. PMID: 33972750 Free PMC article.
-
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease.Front Aging Neurosci. 2016 Mar 30;8:65. doi: 10.3389/fnagi.2016.00065. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27065205 Free PMC article. Review.
-
Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Aging Dis. 2011 Jun;2(3):257-74. Epub 2011 Apr 20. Aging Dis. 2011. PMID: 22396877 Free PMC article.
-
Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.J Signal Transduct. 2014;2014:731350. doi: 10.1155/2014/731350. Epub 2014 Nov 11. J Signal Transduct. 2014. PMID: 25436148 Free PMC article. Review.
-
Brain renin-angiotensin system and dopaminergic cell vulnerability.Front Neuroanat. 2014 Jul 8;8:67. doi: 10.3389/fnana.2014.00067. eCollection 2014. Front Neuroanat. 2014. PMID: 25071471 Free PMC article. Review.
References
-
- Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637–650. - PubMed
-
- Sheikh-Hamad D, Wang YP, Jo OD, Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol. 1993;264:F737–743. - PubMed
-
- Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, et al. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension. 2005;45:804–810. - PubMed
-
- Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension. 2008;51:360–366. This paper shows that the dopamine D5 receptor is the receptor responsible for the dopamine D1-like stimulated proteasomal and c-src dependent degradation of the AT1R receptors. This paper also show that this pathway occurs in adenylyl cyclase uncoupled cells. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials